This inventor holds 8 USPTO granted patents. Top assignee: University of California. Active years: 1996-2003.
Company Filing History:
Years Active: 1996-2003
Title: Glenn C Telling: Innovator in Prion Protein Research
Introduction
Glenn C Telling is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of prion protein research, holding a total of 8 patents. His work focuses on the development of innovative methods for studying and isolating proteins, particularly in the context of prion diseases.
Latest Patents
Among his latest patents, Telling has developed recombinant constructs encoding epitope-tagged PrP proteins. These DNA constructs allow for the purification of epitope-tagged proteins or protein fragments using immunoaffinity chromatography. His work includes the creation of transgenic animals that express epitope-tagged proteins, including prion proteins. Additionally, he has provided methods for distinguishing between the conformational shapes of proteins and convenient techniques for isolating tagged proteins through immunoaffinity chromatographic methods.
Career Highlights
Telling's career is marked by his dedication to advancing the understanding of prion proteins and their implications in neurodegenerative diseases. His innovative approaches have paved the way for new research methodologies and therapeutic strategies.
Collaborations
Throughout his career, Telling has collaborated with notable scientists, including Stanley B Prusiner and Michael R Scott. These collaborations have further enriched his research and contributed to the advancement of the field.
Conclusion
Glenn C Telling's contributions to prion protein research and his innovative patents highlight his role as a leading inventor in this critical area of study. His work continues to influence the scientific community and offers promising avenues for future research.